India's largest pharmaceutical company, Sun Pharmaceutical Industries Limited (“Sun Pharma”), and Jersey City, NJ - headquartered Organon & Co. signed a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for $14.00 per share in cash. The transaction values Organon at $11.75 billion. Organon, established in...
India’s Sun Pharma to Distribute Bayer’s Renal Drug
India's Sun Pharmaceutical Industries Limited and Bayer have signed an agreement allowing Sun Pharma to market and distribute a second brand of the drug finerenone in India under the brand name Lyvelsa. Finerenone is a patented medicine indicated to reduce the risk of sustained decline in kidney function, end-stage kidney...
India’s Sun Pharma Buys Concert Pharmaceuticals
Mumbai headquartered Sun Pharmaceutical Industries Limited, India's largest drugmaker, acquired Lexington, MA-based Concert Pharmaceuticals Inc., for $576 million in cash. Sun Pharma offered Concert $8 per share, representing a premium of 16% to the stock's last close. Concert's lead candidate, deuruxolitinib, is currently being evaluated in a late-stage study as...